Skip to content

Batch information on every product pageTHC < 0.3%Shipped from France10% off when you sign up

CBNMCannabinol methyl ether

Methyl ether of CBN, reported only once in hashish (1973); pharmacology not studied.

Level of detail

Harm-reduction warning

No characterised human dose: animal / in vitro data only. Effect profile, safety margin and acute toxicity are not documented in human clinical practice. Extremely potent compound: severe effects, seizures and deaths reported in the literature.

C₂₂H₂₈O₂

CAS 41935-92-6

Family
PhytocannabinoidMinor
Origin
Tentative identification
Molar mass
324.50 g/mol

Updated on

In plain terms

CBNM is a close relative of CBN whose hydroxyl group is capped by a methyl. It has been reported only once, in hashish in 1973, and how it forms is unknown. Its effects have never been studied.

Receptors and activity

    Bar length follows the measured value (Ki, Kd, EC50 or IC50), on one scale shared by every entry, from 100 µM to 0.1 nM. A target with no cited value has no bar.

    Pharmacology

    Cannabinol methyl ether (CBNM) is the methyl ether, at position 1, of cannabinol: the same fully aromatised benzo[c]chromene nucleus and the same pentyl (C5) chain, but a methoxy in place of the free phenol. It has been reported only once, in 1973, in hashish (Bercht et al., Journal of Chromatography); no later isolation was found, and its origin, in the plant or during resin processing, is not established. No CB1 or CB2 affinity and no pharmacokinetic, metabolism or toxicology data have been published. In the CBN series, removing the phenol at position 1 lowers affinity for both receptors (Mahadevan 2000), but CBNM itself has not been tested. In France, its structure falls within the generic class of benzo[c]chromene derivatives created by the ANSM in 2024, which expressly covers an alkoxy function at position 1 and from which only CBN and CBNA are excluded by name.

    History

    Source
    Cannabis sativa L.: reported only once, in hashish (Bercht et al. 1973); a tentative identification, with no isolation described in the sources consulted. Origin not established: cannabinol, of which it is the methyl ether, forms by oxidation of Δ9-THC (Maioli et al. 2022), but nothing shows whether the methylation occurs in the plant or during processing of the resin.

    Biosynthetic pathway

    No formation pathway has been described. Cannabinol is not an enzymatic product: it results from the oxidation of Δ9-THC (Maioli et al. 2022). No methylating enzyme has been described, and the origin of the methoxy group, in the plant or from resin processing, is not established.

    Classification

    Family, origin and source verification

    Family

    Phytocannabinoid › Minor

    Presence in the plant

    Tentative identification, never isolated

    Chemistry

    Type CBN · C5 side chain · neutral form

    Verification

    Checked on 20 October 2026; some points still await human review.

    Wikipedia (English)

    No dedicated article.

    References

    Identifiers

    Names

    Common name
    Cannabinol methyl ether
    IUPAC name
    1-methoxy-6,6,9-trimethyl-3-pentylbenzo[c]chromene
    Other names
    CBNM-C5 · 4-O-methyl-CBN

    Identifiers

    Formula
    C₂₂H₂₈O₂
    CAS
    41935-92-6
    PubChem CID
    628150(new tab)
    InChIKey
    YEDIZIGYIMTZKP-UHFFFAOYSA-N
    SMILES
    CCCCCC1=CC2=C(C(=C1)OC)C3=C(C=CC(=C3)C)C(O2)(C)C

    Machine-readable entry (JSON)

    LLM ingestion format: a structured superset of the entry (identifiers, binding, versioned legal status). Full corpus.